Market News & Trends
D3 Medicine & Viroclinicas Biosciences Sign Collaboration
d3 Medicine LLC and Viroclinics Biosciences BV recently announced they have signed a non-exclusive Memorandum of Understanding to provide biopharmaceutical customers with an integrated solution…
Increased Government Efforts Aim to Reinvigorate a Stagnant Antibiotics Market
Christopher Pace, PhD, GlobalData’s Analyst covering Infectious Diseases, says “On July 1, 2014, UK Prime Minister David Cameron revealed the formation of an independent review panel…
MannKind Corporation Announces FDA Approval of Novel, Rapid-Acting Inhaled Insulin for the Treatment of Diabetes
MannKind Corporation (Nasdaq:MNKD) recently announced that the US Food & Drug Administration (FDA) has approved AFREZZA (insulin human) Inhalation Powder to improve glycemic control in…
Bionomics & Merck Enter New Research Collaboration
Bionomics Limited recently announced it has entered into an exclusive Research Collaboration and License Agreement with Merck, known as MSD outside the United States and…
Johnson & Johnson Innovation, Janssen Biotech & Dana-Farber Cancer Institute Launch $10-Million Collaboration
Johnson & Johnson Innovation, Boston and Janssen Biotech, Inc. recently announced a 3-year immuno-oncology lung cancer collaboration with the Dana-Farber Cancer Institute. Through the collaboration,…
Dimension Therapeutics & Bayer Sign $252-Million Deal
Dimension Therapeutics recently announced it has entered into a collaboration with Bayer HealthCare for the development and commercialization of a novel gene therapy for the…
Pluristem Selects Rotator Cuff Repair as New Orthopedic Indication
Pluristem Therapeutics Inc. recently announced it has selected rotator cuff repair as the second indication in its orthopedic clinical program. The company's PLacental eXpanded (PLX)…
SMARTag Toxicology Study Demonstrates Decreased Mortality & Better Tolerability
Redwood Bioscience and Catalent Pharma Solutions recently announced the results of an in vivo toxicology study, demonstrating that an Antibody Drug Conjugate (ADC) generated using…
Tech Group Receives 2014 Lilly Global Supplier Award
West Pharmaceutical Services, Inc. recently announced that its Tech Group Rockford facility has received a 2014 Lilly Global Supplier Award. Lilly presented the award at…
Oxford Biomedical Research Centre Signs Contract With GENALICE
GENALICE recently announced that the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre’s Molecular Diagnostics Centre has signed a contract for a larger…
Crown Bioscience Reveals Strategy for Combining Drug Therapy With Irradiation
Crown Bioscience, Inc. has developed treatment combination strategies with image-guided micro-irradiation (IGMI) to overcome drug resistance. These novel strategies at the preclinical stage of drug…
EMD Millipore Launches RNA Reprogramming Technology
EMD Millipore, the Life Science division of Merck KGaA of Darmstadt, Germany, recently launched Simplicon RNA Reprogramming Technology, which uses synthetic self-replicating RNA to create…
CEA-Leti & Akrivis Technologies to Develop Nanomedicine Platform for High Payload Targeted Drug Delivery
CEA-Leti and Akrivis Technologies, LLC recently announced their collaboration to develop an extremely adaptable, efficient, and highly targeted drug delivery platform for chemotherapy and other…
Can Regenerative Medicine be the Cure for Cancer & Other Deadly Diseases?
Regenerative medicine has the potential to transform healthcare all over the world and usher human health into a new era of wellness. Currently, the majority…
Exostar & SAFE-BioPharma Announce Strategic Partnership
Exostar and SAFE-BioPharma Association recently announced a new partnership that will enable Exostar to issue non-public key infrastructure (PKI) identity credentials at Levels of Assurance…
Can Regenerative Medicine be the Cure for Cancer & Other Deadly Diseases?
Regenerative medicine has the potential to transform healthcare all over the world and usher human health into a new era of wellness. Currently, the majority…
Delivering Value From Drug-Device Strategic Partnerships
By: Alan Shortall, Chairman and CEO of Unilife The formation of a strategic alliance this week between Sanofi and Medtronic to enhance the provision of…
Isis Pharmaceuticals Earns $15 Million From AstraZeneca
Isis Pharmaceuticals, Inc.recently announced that AstraZeneca has initiated a Phase I clinical study of ISIS-ARRx in patients with cancer. Isis earned a $15-million milestone payment…
Aduro Biotech Secures $55 Million Series C Financing
Aduro BioTech, Inc. recently announced the closing of a $55 million Series C financing. New investor Johnson & Johnson Development Corporation (JJDC) joined the Morningside…
Ligand Partner GSK Announces Results of Phase III PETIT2 Study
Ligand Pharmaceuticals Incorporated recently announced that its partner, GlaxoSmithKline (GSK) plc, presented the results from the Phase III PETIT2 study evaluating the efficacy of eltrombopag…
